Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Details )

v3.26.1
Stockholders' Equity (Details ) - Twin Vee [Member] - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]        
Number of options outstanding at beginning of period 6,239 5,757 5,757  
Weighted average exercise price at beginning of period $ 966.77 $ 1,084.53 $ 1,084.53  
Weighted average remaining life (years) 7 years 4 months 13 days 5 years 14 days 7 years 5 months 8 days 5 years 14 days
Grant date fair value of options at beginning of period $ 1,597,681 $ 1,708,693 $ 1,708,693  
Number of options, Granted    
Weighted average exercise price, Granted $ 0 $ 0    
Grant date fair value of options, Granted $ 0 $ 0    
Number of options, Exercised    
Weighted average exercise price, Exercised $ 0 $ 0    
Grant date fair value of options, exercised $ 0 $ 0    
Number of options, Expired (151) (112)    
Weighted average exercise price, Expired $ (745.43) $ (1,029.66)    
Grant date fair value of options, Expired $ (22,916) $ (34,761)    
Number of options, Forfeited/canceled    
Weighted average exercise price, Forfeited/canceled $ 0 $ 0    
Grant date fair value of options, Forfeited/canceled $ 0 $ 0    
Number of options outstanding at ending of period 6,088 5,645 6,239 5,757
Weighted average exercise price at ending of period $ 972.26 $ 1,085.62 $ 966.77 $ 1,084.53
Grant date fair value of options at ending of period $ 1,574,765 $ 1,673,932 $ 1,597,681 $ 1,708,693
Number of options, Exercisable options 4,677 3,442    
Weighted average exercise price, Exercisable options $ 1,225.61 $ 1,524.93    
Weighted average remaining life (years) 6 years 10 months 24 days 7 years 3 months 10 days    
Grant date fair value of exercisable options at of period $ 1,492,478 $ 1,396,565